Russell Investments Group, Ltd. Seres Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 18,300 shares of MCRB stock, worth $15,555. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,300

Previous 21,998 16.81%

Holding current value

$15,555

Previous $15,000 13.33%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.7 - $1.48 $2,588 - $5,473	-3,698 Reduced 16.81%	18,300 $17,000
Q2 2024 Aug 08, 2024	BUY	$0.56 - $1.19 $2,070 - $4,400	3,698 Added 20.21%	21,998 $15,000
Q3 2022 Nov 04, 2022	SELL	$3.5 - $7.2 $164,489 - $338,378	-46,997 Reduced 71.97%	18,300 $117,000
Q2 2022 Jul 29, 2022	SELL	$2.7 - $7.62 $15,330 - $43,266	-5,678 Reduced 8.0%	65,297 $222,000
Q1 2022 May 05, 2022	SELL	$6.3 - $8.84 $145,845 - $204,646	-23,150 Reduced 24.59%	70,975 $504,000
Q4 2021 Jan 21, 2022	BUY	$6.02 - $11.43 $456,466 - $866,679	75,825 Added 414.34%	94,125 $782,000
Q1 2021 May 10, 2021	BUY	$17.66 - $28.92 $155,107 - $254,004	8,783 Added 92.29%	18,300 $376,000
Q4 2020 Feb 08, 2021	BUY	$23.25 - $37.73 $221,270 - $359,076	9,517 New	9,517 $233,000
Q3 2020 Nov 09, 2020	SELL	$3.74 - $28.74 $276,890 - $2.13 Million	-74,035 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$3.04 - $6.2 $32,531 - $66,346	10,701 Added 16.9%	74,035 $352,000
Q1 2020 May 06, 2020	BUY	$2.64 - $3.82 $11,539 - $16,697	4,371 Added 7.41%	63,334 $225,000
Q4 2019 Jan 29, 2020	BUY	$2.99 - $4.42 $176,299 - $260,616	58,963 New	58,963 $202,000
Q2 2019 Aug 09, 2019	SELL	$2.28 - $7.35 $56,087 - $180,810	-24,600 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$4.83 - $7.21 $11,592 - $17,304	2,400 Added 10.81%	24,600 $169,000
Q4 2018 Feb 11, 2019	BUY	$4.52 - $8.88 $100,343 - $197,136	22,200 New	22,200 $101,000
Q2 2018 Aug 08, 2018	SELL	$6.91 - $9.55 $80,156 - $110,780	-11,600 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$7.34 - $11.16 $12,478 - $18,972	1,700 Added 17.17%	11,600 $85,000
Q4 2017 Feb 06, 2018	BUY	$9.15 - $12.64 $90,585 - $125,136	9,900	9,900 $102,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

40.5M

Call Options Held

304K

Put Options Held

471K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $105M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Seres Therapeutics, Inc. Transaction History